Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
305.98
-8.12 (-2.59%)
Sep 29, 2026, 11:42 AM EDT - Market open
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or -30.88% compared to the previous year.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$6,181,745
Profits / Employee
$4,196,170
Market Cap
6.10B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
LGND News
- 4 days ago - Ligand initiated with an Overweight at Barclays - TheFly
- 5 days ago - Wainwright sees upside in Ligand after new CAR-T investment in AvenCell - TheFly
- 5 days ago - Ligand enters financing agreement with AvenCell for up to $47M - TheFly
- 5 days ago - Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million - GlobeNewsWire
- 6 days ago - Ligand price target raised to $397 from $390 at Citi - TheFly
- 7 days ago - Ligand enters royalty agreement with Sydnexis for Ryjunea - TheFly
- 7 days ago - Sydnexis Announces Royalty Agreement with Ligand for Ryjunea® - Business Wire
- 7 days ago - Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners - PRNewsWire